![[Home]](/logosmall.gif)
A report on the Clinical Biotechnology and Research Day can be found here: http://www.biovalley.ch/news/news_article.html?id=25
The SMPA general assembly 05 will take place on October 22nd, 2005 in Basel. This one-day meeting will focus on Biotechnology and clinical research. Aspects of research in an industrial environment, of Biotech spin-offs and venture capital will be outlined by leading experts and CEO’s of Biotech companies.
We are pleased that our “Biotechnology and Clinical Research Day” will be part of the Basel Life Science Week that is organized by the Biovalley Initiative (http://www.biovalley.com/).
Location: Pharmacenter Basel, (Map/Travel information)
Schedule: The meeting starts at 10:00 and ends 17:30.
10:00 Registration
10:30 Welcome and Introduction
David Winkler, MD, PhD, and Lukas Jeker MD, PhD, SMPA Board
10:40 Speedel – a Different, a Special Biotech
Dr. Alice Huxley, CEO and President, Speedel (http://www.speedel.com)
11:10 Factors for Actelion’s Past, Present and Future Success
Dr. Walter Fischli, Senior Vice President and Co-Founder of Actelion Pharmaceuticals Ltd (http://www.actelion.com)
12:00 Buffet lunch
12:45 SMPA Business Meeting
General Assembly 05 (for SMPA members)
13:15 From Basic Research Results to Clinical Practice
Dr. Gregor Strasser, CEO AO Foundation (http://www.aofoundation.org)
13:50 Global Biotechnology Report 2005
Jürg Zürcher, Industry Leader Health Sciences, Ernst & Young (http://www.ey.com/global/content.nsf/Switzerland_D/Willkommen)
14:20 Coffee Break
14:50 Financing Strategies for Biotech Companies
Prof. Apl. Dr. Erich Platzer, HBM Bioventure (http://www.hbmbioventures.com/)
15:20 Risks and Benefits in the Biotech Industry
Peter Friedli, Investment Manager, President of New Venturetec (http://www.newventuretec.com/)
16:00 Key Factors for Successful Biotech Start-Ups
Roundtable discussion with Speakers
16:40 Closing Remarks
16:45 Farewell
For SMPA members, lunch is served free, for guests we kindly ask for a contribution of SFr. 15.-.
We owe great thanks to our financial partners for their support. Main sponsors are the AO foundation, Davos (http://www.aofoundation.org/wps/portal/ari) and Ernst&Young (http://www.ey.com). The meeting is also supported by the DC-Bank Bern (http://www.dcbank.ch) and Synthes (http://www.synthes.com).
We are looking forward to seeing you at our “Clinical Biotechnology and Research Day” in Basel!
The SMPA thanks the main sponsors AO Foundation, Ernst & Young, Synthes and the DC-Bank Bern